Taysha Gene Therapies Inc (TSHA) — Cash Flow Reinvestment Rate
Taysha Gene Therapies Inc (TSHA) has a Cash Flow Reinvestment Rate of 0.33x as of December 2022, reinvesting $4.68 Million (capex $2.31 Million plus investments $-2.37 Million) from operating cash flow of $14.28 Million. Check TSHA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Taysha Gene Therapies Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Taysha Gene Therapies Inc across 1 annual periods. Explore Taysha Gene Therapies Inc (TSHA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Taysha Gene Therapies Inc (2019–2019)
Year-by-year capital reinvestment analysis for Taysha Gene Therapies Inc. For live market cap and broader valuation context, see TSHA market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.61x | $82.00K | $135.00K | $82.00K | — |